Foreign companies tackling generic trademarks, such as Baracle and Lavix

Multinational pharmaceutical companies which claimed invalidation trials for trademark of generic drugs for the reason of confusion with their original products were defeated in a series.

Although the original companies overuse trademark trials as a defensive strategy against generics, the results are poor.

Since the judicial authorities see the primary consumer as medical professionals con...